CVE-2017-17678

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Cross-site Scripting
ProviderTypeBase ScoreAtk. VectorAtk. ComplexityPriv. RequiredVector
NISTNIST
6.1 MEDIUM
NETWORK
LOW
NONE
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
mitreCNA
---
---
CVEADP
---
---
Base Score
CVSS 3.x
EPSS Score
Percentile: 60%
VendorProductVersion
bmcremedy_mid-tier
9.1:sp3
𝑥
= Vulnerable software versions
Common Weakness Enumeration
References
http://bmc.com
http://remedy.com
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
https://seclists.org/fulldisclosure/2017/Oct/52
http://bmc.com
http://remedy.com
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
https://seclists.org/fulldisclosure/2017/Oct/52